UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review

Medicina (Kaunas, Lithuania), 2019-08, Vol.55 (9), p.525

2019

Volltextzugriff (PDF)

An Insight into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions

The international journal of neuropsychopharmacology, 2019-04, Vol.22 (4), p.270-277

2019

Volltextzugriff (PDF)

Novel psychoactive substances of interest for psychiatry

World psychiatry, 2015-02, Vol.14 (1), p.15-26

2015

Volltextzugriff (PDF)

Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review

Brain sciences, 2018-04, Vol.8 (4), p.73

2018

Volltextzugriff (PDF)

The e-psychonaut drugs’ psychopharmacology

Current opinion in pharmacology, 2021-04, Vol.57, p.165-174

2021

Volltextzugriff (PDF)

Beyond the ‘purple drank’: Study of promethazine abuse according to the European Medicines Agency adverse drug reaction reports

Journal of psychopharmacology (Oxford), 2021-06, Vol.35 (6), p.681-692

2021

Volltextzugriff (PDF)

Gamma hydroxybutyrate (GHB), gamma butyrolactone (GBL) and 1,4-butanediol (1,4-BD; BDO): A literature review with a focus on UK fatalities related to non-medical use

Neuroscience and biobehavioral reviews, 2015-06, Vol.53, p.52-78

2015

Volltextzugriff (PDF)

'New/Designer Benzodiazepines': An Analysis of the Literature and Psychonauts' Trip Reports

Current neuropharmacology, 2020-01, Vol.18 (9), p.809-837

2020

Volltextzugriff (PDF)

Characteristics of deaths associated with kratom use

Journal of psychopharmacology (Oxford), 2019-09, Vol.33 (9), p.1102-1123

2019

Volltextzugriff (PDF)

Focus on Over-the-Counter Drugs' Misuse: A Systematic Review on Antihistamines, Cough Medicines, and Decongestants

Frontiers in psychiatry, 2021-05, Vol.12, p.657397-657397

2021

Volltextzugriff (PDF)

Deaths in the Lesbian, Gay, Bisexual and Transgender United Kingdom Communities Associated with GHB and Precursors

Current drug metabolism, 2018-01, Vol.19 (13), p.1086-1099

2018

Volltextzugriff (PDF)

The Benzydamine Experience: A Systematic Review of Benzydamine Abuse

Current neuropharmacology, 2021-10, Vol.19 (10), p.1728-1737

2021

Volltextzugriff (PDF)

The use of new psychoactive substances (NPS) in young people and their role in mental health care: a systematic review

Expert review of neurotherapeutics, 2019-12, Vol.19 (12), p.1253-1264

2019

Volltextzugriff (PDF)

Knowledge and Use of Over-the-counter Drugs in Italy: An Exploratory Survey-based Study in the General Population

Current neuropharmacology, 2023, Vol.21 (1), p.133-141

2023

Volltextzugriff (PDF)

An index of fatal toxicity for new psychoactive substances

Journal of psychopharmacology (Oxford), 2018-07, Vol.32 (7), p.793-801

2018

Volltextzugriff (PDF)

Alprazolam-related deaths in Scotland, 2004–2020

Journal of psychopharmacology (Oxford), 2022-09, Vol.36 (9), p.1020-1035

2022

Volltextzugriff (PDF)

Is There a Risk for Semaglutide Misuse? Focus on the Food and Drug Administration's FDA Adverse Events Reporting System (FAERS) Pharmacovigilance Dataset

Pharmaceuticals (Basel, Switzerland), 2023-07, Vol.16 (7), p.994

2023

Volltextzugriff (PDF)

Exploring the nexus of binge eating disorder (BED), New Psychoactive Substances (NPS), and misuse of pharmaceuticals: charting a path forward

Expert opinion on pharmacotherapy, 2023-12, Vol.24 (18), p.1915-1918

2023

Volltextzugriff (PDF)

COVID-19: The Hidden Impact on Mental Health and Drug Addiction

Frontiers in psychiatry, 2020-07, Vol.11, p.767-767

2020

Volltextzugriff (PDF)

Recreational ketamine-related deaths notified to the National Programme on Substance Abuse Deaths, England, 1997–2019

Journal of psychopharmacology (Oxford), 2021-11, Vol.35 (11), p.1324-1348

2021

Volltextzugriff (PDF)

Pharmacovigilance Signals of the Opioid Epidemic over 10 Years: Data Mining Methods in the Analysis of Pharmacovigilance Datasets Collecting Adverse Drug Reactions (ADRs) Reported to EudraVigilance (EV) and the FDA Adverse Event Reporting System (FAERS)

Pharmaceuticals (Basel, Switzerland), 2022-05, Vol.15 (6), p.675

2022

Volltextzugriff (PDF)

Impact of the UK Psychoactive Substances Act on awareness, use, experiences and knowledge of potential associated health risks of novel psychoactive substances

British journal of clinical pharmacology, 2020-03, Vol.86 (3), p.505-516

2020

Volltextzugriff (PDF)

The Bridge Between Classical and "Synthetic"/Chemical Psychoses: Towards a Clinical, Psychopathological, and Therapeutic Perspective

Frontiers in psychiatry, 2019-11, Vol.10, p.851

2019

Volltextzugriff (PDF)

The e-Psychonauts' ‘Spiced' World; Assessment of the Synthetic Cannabinoids' Information Available Online

Current neuropharmacology, 2020-01, Vol.18 (10), p.966-1051

2020

Volltextzugriff (PDF)

Ibogaine/Noribogaine in the Treatment of Substance Use Disorders: A Systematic Review of the Current Literature

Current neuropharmacology, 2023-01, Vol.21 (11), p.2178-2194

2023

Volltextzugriff (PDF)

1 – 25 von 198

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(175)
Mit Volltextzugriff
(163)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review

An Insight into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions

Novel psychoactive substances of interest for psychiatry

Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review

The e-psychonaut drugs’ psychopharmacology

Beyond the ‘purple drank’: Study of promethazine abuse according to the European Medicines Agency adverse drug reaction reports

Gamma hydroxybutyrate (GHB), gamma butyrolactone (GBL) and 1,4-butanediol (1,4-BD; BDO): A literature review with a focus on UK fatalities related to non-medical use

'New/Designer Benzodiazepines': An Analysis of the Literature and Psychonauts' Trip Reports

Characteristics of deaths associated with kratom use

Focus on Over-the-Counter Drugs' Misuse: A Systematic Review on Antihistamines, Cough Medicines, and Decongestants

Deaths in the Lesbian, Gay, Bisexual and Transgender United Kingdom Communities Associated with GHB and Precursors

The Benzydamine Experience: A Systematic Review of Benzydamine Abuse

The use of new psychoactive substances (NPS) in young people and their role in mental health care: a systematic review

Knowledge and Use of Over-the-counter Drugs in Italy: An Exploratory Survey-based Study in the General Population

An index of fatal toxicity for new psychoactive substances

Alprazolam-related deaths in Scotland, 2004–2020

Is There a Risk for Semaglutide Misuse? Focus on the Food and Drug Administration's FDA Adverse Events Reporting System (FAERS) Pharmacovigilance Dataset

Exploring the nexus of binge eating disorder (BED), New Psychoactive Substances (NPS), and misuse of pharmaceuticals: charting a path forward

COVID-19: The Hidden Impact on Mental Health and Drug Addiction

Recreational ketamine-related deaths notified to the National Programme on Substance Abuse Deaths, England, 1997–2019

Pharmacovigilance Signals of the Opioid Epidemic over 10 Years: Data Mining Methods in the Analysis of Pharmacovigilance Datasets Collecting Adverse Drug Reactions (ADRs) Reported to EudraVigilance (EV) and the FDA Adverse Event Reporting System (FAERS)

Impact of the UK Psychoactive Substances Act on awareness, use, experiences and knowledge of potential associated health risks of novel psychoactive substances

The Bridge Between Classical and "Synthetic"/Chemical Psychoses: Towards a Clinical, Psychopathological, and Therapeutic Perspective

The e-Psychonauts' ‘Spiced' World; Assessment of the Synthetic Cannabinoids' Information Available Online

Ibogaine/Noribogaine in the Treatment of Substance Use Disorders: A Systematic Review of the Current Literature

Suchergebnisse filtern